|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| C12N 15/11 | (2006.01) | ||
| A61K 31/712 | (2006.01) | ||
| A61K 31/7125 | (2006.01) |
| (11) | Number of the document | 3374509 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16798440.0 |
| Date of filing the European patent application | 2016-11-11 | |
| (97) | Date of publication of the European application | 2018-09-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation | 2021-03-10 |
| (86) | Number | PCT/EP2016/077383 |
| Date | 2016-11-11 |
| (87) | Number | WO 2017/081223 |
| Date | 2017-05-18 |
| (30) | Number | Date | Country code |
| 15194367 | 2015-11-12 | EP | |
| 16189502 | 2016-09-19 | EP |
| (72) |
COSTA, Veronica, CH
HEDTJÄRN, Maj, DK
HOENER, Marius, CH
JAGASIA, Ravi, CH
JENSEN, Mads Aaboe, DK
PATSCH, Christoph, CH
PEDERSEN, Lykke, DK
RASMUSSEN, Soren Vestergaard, DK
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Oligonukleotidai, skirti sukelti tėvinio UBE3A raišką |
| OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 10 | 231.00 EUR |
| 2026-11-11 |